Nuformix (LON:NFX) Stock Price Down 12.7% – Here’s What Happened

Nuformix plc (LON:NFX)’s stock price dropped 12.7% during mid-day trading on Thursday . The stock traded as low as GBX 0.06 ($0.00) and last traded at GBX 0.06 ($0.00). 1,778,717 shares traded hands during mid-day trading, a decline of 69% from the average daily volume of 5,659,305 shares. The stock had previously closed at GBX 0.06 ($0.00).

Nuformix Stock Performance

The company has a quick ratio of 3.35, a current ratio of 1.12 and a debt-to-equity ratio of 1.17. The business has a 50 day simple moving average of GBX 0.10 and a two-hundred day simple moving average of GBX 0.15. The firm has a market cap of £471,103.25, a PE ratio of -1.63 and a beta of 1.22.

About Nuformix

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.